Compile Data Set for Download or QSAR
maximum 50k data
Found 88 Enz. Inhib. hit(s) with all data for entry = 50036060
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003524(CHEMBL3216197 | [4-(2,2-Diphenyl-propionyl)-pipera...)
Affinity DataIC50:  1.90nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003499(CHEMBL338940 | [4-(3-Hydroxy-3,3-diphenyl-propiony...)
Affinity DataIC50:  2.70nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003525(CHEMBL133742 | [4-(2,3-Diphenyl-acryloyl)-piperazi...)
Affinity DataIC50:  7.5nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003506(CHEMBL322184 | CHEMBL545771 | {4-[2-(Benzhydryl-am...)
Affinity DataIC50:  9.10nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003522((4-Diphenylacetyl-piperazin-1-yl)-pyridin-3-yl-ace...)
Affinity DataIC50:  10nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003473(CHEMBL317193 | [4-(3,3-Diphenyl-acryloyl)-piperazi...)
Affinity DataIC50:  10nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003514(CHEMBL3216401 | [4-(2-Benzyl-3-phenyl-propionyl)-p...)
Affinity DataIC50:  11nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003503(1-(3,3-Diphenyl-propionyl)-4-(pyridin-3-ylamino)-p...)
Affinity DataIC50:  15nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003490(CHEMBL101245 | [4-(3,3-Diphenyl-propionyl)-piperaz...)
Affinity DataIC50:  20nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003494(CHEMBL336612 | [4-(3,3-Diphenyl-propionyl)-piperaz...)
Affinity DataIC50:  21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003510(CHEMBL103753 | [4-(3-Hydroxy-3,3-diphenyl-propiony...)
Affinity DataIC50:  21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003519(CHEMBL3216182 | [4-(2-Phenyl-propionyl)-piperazin-...)
Affinity DataIC50:  21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003536((1-Diphenylacetyl-piperidin-4-yl)-pyridin-3-yl-ace...)
Affinity DataIC50:  21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003548(CHEMBL335853 | [4-(2,2-Diphenyl-thioacetyl)-pipera...)
Affinity DataIC50:  23nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003544(CHEMBL132852 | {4-[2-(Benzyl-phenyl-amino)-acetyl]...)
Affinity DataIC50:  24nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003497(CHEMBL134123 | {1-[2-(Benzhydryl-amino)-acetyl]-pi...)
Affinity DataIC50:  24nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003485(CHEMBL134143 | [1-(3,3-Diphenyl-propionyl)-piperid...)
Affinity DataIC50:  26nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003527(4-(Cyano-pyridin-3-yl-methyl)-piperazine-1-carboxy...)
Affinity DataIC50:  26nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003523(CHEMBL544607 | [4-(2-Dibenzylamino-acetyl)-piperaz...)
Affinity DataIC50:  32nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003543(CHEMBL554463 | {4-[2-(1-Phenyl-ethylamino)-acetyl]...)
Affinity DataIC50:  36nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003552(CHEMBL555567 | {4-[2-(Benzhydryl-amino)-ethyl]-pip...)
Affinity DataIC50:  36nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003484(CHEMBL336816 | N-{2-[4-(Cyano-pyridin-3-yl-methyl)...)
Affinity DataIC50:  36nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003474(CHEMBL545773 | {4-[2-(1,2-Diphenyl-ethylamino)-ace...)
Affinity DataIC50:  50nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003558(CHEMBL3216867 | [4-(3,3-Diphenyl-propionyl)-pipera...)
Affinity DataIC50:  51nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003489(CHEMBL103801 | {4-[3-(Benzhydryl-amino)-propionyl]...)
Affinity DataIC50:  53nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003556(CHEMBL133457 | {4-[3-(Benzhydryl-amino)-propionyl]...)
Affinity DataIC50:  55nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003528(CHEMBL545072 | {4-[2-(Benzhydryl-methyl-amino)-ace...)
Affinity DataIC50:  60nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003513(CHEMBL423524 | [4-(2-Naphthalen-1-yl-acetyl)-piper...)
Affinity DataIC50:  76nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003520(CHEMBL552805 | {4-[2-(3,3-Diphenyl-propylamino)-ac...)
Affinity DataIC50:  86nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003501(3,3-Diphenyl-1-[4-(pyridin-3-ylamino)-piperidin-1-...)
Affinity DataIC50:  87nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50000714(3-[4-(2-Chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a...)
Affinity DataIC50:  91nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003537(CHEMBL134094 | [4-(2-Phenylamino-acetyl)-piperazin...)
Affinity DataIC50:  130nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003493(1-[2-(Benzhydryl-amino)-acetyl]-4-(pyridin-3-ylami...)
Affinity DataIC50:  200nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003475(CHEMBL543420 | {4-[2-(2,2-Diphenyl-ethylamino)-ace...)
Affinity DataIC50:  220nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003516(CHEMBL335044 | [4-(2,3-Diphenyl-propionyl)-piperaz...)
Affinity DataIC50:  230nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003504(CHEMBL3217094 | [4-(2-Benzylamino-acetyl)-piperazi...)
Affinity DataIC50:  240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003511((4-{2-[Methyl-(1-phenyl-ethyl)-amino]-acetyl}-pipe...)
Affinity DataIC50:  240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003526(2-[4-(Cyano-pyridin-3-yl-methyl)-piperazin-1-yl]-N...)
Affinity DataIC50:  240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003551(2-(4-Diphenylacetyl-piperazin-1-yl)-2-pyridin-3-yl...)
Affinity DataIC50:  240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003509(CHEMBL335556 | [4-(4-Phenyl-butyryl)-piperazin-1-y...)
Affinity DataIC50:  260nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003486(4-(Cyano-pyridin-3-yl-methyl)-piperazine-1-carboxy...)
Affinity DataIC50:  360nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003481(CHEMBL3215746 | Pyridin-3-yl-{4-[3-(3,4,5-trimetho...)
Affinity DataIC50:  400nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003557(CHEMBL559013 | [4-(2-1H-Indol-3-yl-acetyl)-piperaz...)
Affinity DataIC50:  450nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003496(CHEMBL133425 | Pyridin-3-yl-{4-[2-(3,4,5-trimethox...)
Affinity DataIC50:  460nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003488(3,3-Diphenyl-1-(4-pyridin-3-ylmethyl-piperazin-1-y...)
Affinity DataIC50:  520nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003517(CHEMBL3215980 | [4-(3-Phenyl-propionyl)-piperazin-...)
Affinity DataIC50:  520nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50368448(CHEMBL1203313)
Affinity DataIC50:  530nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003542(CHEMBL542731 | [4-(3,3-Diphenyl-propyl)-piperazin-...)
Affinity DataIC50:  630nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003530(CHEMBL340989 | N-{2-[4-(Cyano-pyridin-4-yl-methyl)...)
Affinity DataIC50:  680nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-activating factor receptor(Cavia porcellus)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003505(CHEMBL132636 | [4-(2-Naphthalen-2-yl-acetyl)-piper...)
Affinity DataIC50:  720nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: